With consistent nightly use as part of a supervised skincare protocol, Youthful Cream supports:

Slowing and reduction of unwanted facial terminal hair growth in androgen-sensitive zones through intrafollicular DHT suppression

Reversal of estrogen-related skin thinning, dryness, and laxity through restored estrogenic procollagen and hyaluronic acid signaling

Smoothing of fine lines and improvement in deeper wrinkle structure through three-pathway collagen stimulation

Dual MMP suppression — building and protecting structural collagen simultaneously

Improved skin firmness, elasticity, and dermal thickness

Accelerated epidermal cell turnover with minimized retinoid irritation through niacinamide tolerability buffering

Triple-mechanism pigmentation correction — sunspot and dyschromia reduction, uneven tone improvement, and post-inflammatory hyperpigmentation fading

Reduced sebum production and refined pore appearance through dual androgenic and non-androgenic sebaceous modulation

Improved skin texture and reduced skin coarsening associated with androgen-dominant skin changes

Strengthened stratum corneum barrier with reduced transepidermal water loss and environmental trigger sensitivity

Triple sebaceous modulation from three complementary mechanisms

A progressively clearer, firmer, more even-toned, and hormonally balanced complexion with continued use

Results vary by individual. Early improvements in skin texture, hydration, and surface redness are often noticeable within two to four weeks. Meaningful collagen remodeling, wrinkle reduction, and pigmentation improvement typically develop over 8–12 weeks. Reduction in facial terminal hair growth is a slower process — follicular biology changes gradually across hair growth cycles — with measurable results typically emerging over three to six months of consistent nightly use. Hair growth management requires ongoing therapy; results diminish when treatment is discontinued.

For evening / bedtime use only. Tretinoin is photolabile and degrades on UV exposure. It also significantly increases photosensitivity. Apply at night, every night.

Application Instructions:

Cleanse the face thoroughly and pat completely dry. Allow skin to dry for 10–15 minutes before applying — tretinoin penetrates more aggressively into damp skin, increasing irritation risk particularly during the adjustment period.

Dispense a pea-sized amount — sufficient for the full face and neck. More product does not improve outcomes and increases irritation risk.

Apply in a thin, even layer to the face and neck, avoiding the immediate eye area, inner corners of the nose, and lip margins where skin is thinnest and most reactive.

Allow to absorb fully before applying any other products. A fragrance-free moisturizer may be layered on top if additional occlusion is desired.

Wash hands thoroughly after application — finasteride can be absorbed through the skin of others who handle it, with potential consequences for pregnant women and children (see Warnings below).

Starting Protocol: Patients new to retinoid therapy should begin with every-other-night application for the first one to two weeks, advancing to nightly as tolerated. Niacinamide's barrier-protective activity meaningfully reduces adjustment irritation, but individual sensitivity varies. The redness and mild peeling of the retinoid adjustment period — when it occurs — is expected and transient.

Morning Routine: Daily broad-spectrum SPF 30 or higher is mandatory throughout tretinoin therapy. Unprotected UV exposure during active tretinoin use significantly increases sunburn risk and can worsen hyperpigmentation. This is non-negotiable.

Youthful Cream is a prescription-only compounded medication containing a teratogenic retinoid, a topical antiandrogen, and a topical estrogen. Full patient counseling is required before initiating therapy.

Contraindications:

Pregnancy: Absolutely contraindicated. See Critical Safety Warning above.

Breastfeeding: Safety of topical tretinoin, finasteride, and estriol during lactation has not been established. Use is not recommended; consult your provider.

Hormone-sensitive malignancies: Estriol is an estrogen; finasteride modulates androgen metabolism. Patients with a personal history of estrogen receptor-positive breast cancer, endometrial cancer, hormone-sensitive prostate conditions, or other hormone-sensitive malignancies should discuss use with their oncologist before initiating therapy.

Active inflammatory skin conditions: Do not apply to actively inflamed, sunburned, broken, or eczematous skin. Tretinoin has been reported to cause severe irritation on eczematous skin.

Known retinoid sensitivity: Patients with documented allergy or intolerance to tretinoin or other retinoids should not use this product.

Known hypersensitivity: Patients with documented allergy to finasteride, estriol, or niacinamide should not use this product.

Potential Side Effects:

Most common — tretinoin adjustment period:

Redness, peeling, or dryness during the first two to four weeks — expected, transient, and meaningfully reduced by niacinamide's tolerability buffering

Increased photosensitivity — managed by mandatory daily SPF

Temporary heightened environmental sensitivity

Less common:

Mild local skin sensitivity to estriol or finasteride components in reactive-skin patients

Rare mild systemic estrogenic effects (breast tenderness) if significant systemic absorption occurs — uncommon at compounded facial concentrations; report to your provider

Contact dermatitis in patients with sensitivity to any formula component

Finasteride-specific note: Oral finasteride is associated with sexual side effects in men at systemic therapeutic doses. At the low concentrations used in topical facial compounding in women, systemic finasteride absorption is minimal and these effects are not an expected concern. However, patients who note any unexpected hormonal symptoms should report them to their provider.

Other topical retinoids: Concurrent use of additional retinoid-class products in the same facial area dramatically increases irritation risk. Do not combine without provider direction.

Benzoyl peroxide: Inactivates tretinoin on direct contact. Do not apply simultaneously or to the same area.

Topical exfoliating acids: AHAs and BHAs applied concurrently increase barrier disruption risk, particularly during the retinoid adjustment period.

Photosensitizing medications: Certain antibiotics, diuretics, and antifungals increase photosensitivity additively with tretinoin. Daily SPF is essential when any photosensitizing agent is part of the treatment regimen.

Oral hormonal therapies: Patients on systemic menopausal hormone therapy, oral contraceptives, or other estrogen- or androgen-modulating treatments should ensure all prescribing providers are aware of the estriol and finasteride components of this formula.

5-alpha reductase inhibitors (oral): Patients on systemic finasteride or dutasteride for any indication should inform their provider — combined systemic and topical exposure should be considered in the overall treatment plan.

Copper-chelating topicals / high-dose zinc: May interact with skin barrier function; discuss concurrent use of significant zinc supplementation with your provider.

Store at room temperature, 68°F – 77°F (20°C – 25°C), away from direct heat, humidity, and light

Keep container tightly closed

Tretinoin is light-sensitive — store in original packaging, away from direct sunlight

Do not freeze

Keep strictly out of reach of children

Pregnant women must not handle this product

Do not use beyond the labeled expiration date